Nationwide Fund Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-108,643
| Closed | -$2.01M | – | 2649 |
|
|
2017
Q3 | $2.01M | Sell |
108,643
-17,451
| -14% | -$323K | 0.01% | 1444 |
|
|
2017
Q2 | $2.13M | Buy |
126,094
+13,382
| +12% | +$226K | 0.01% | 1401 |
|
|
2017
Q1 | $1.51M | Buy |
112,712
+72,361
| +179% | +$966K | 0.01% | 1535 |
|
|
2016
Q4 | $607K | Sell |
40,351
-1,987
| -5% | -$29.9K | ﹤0.01% | 2073 |
|
|
2016
Q3 | $495K | Hold |
42,338
| – | – | ﹤0.01% | 2187 |
|
|
2016
Q2 | $457K | Buy |
42,338
+3,030
| +8% | +$32.7K | ﹤0.01% | 2200 |
|
|
2016
Q1 | $363K | Sell |
39,308
-10,633
| -21% | -$98.2K | ﹤0.01% | 2257 |
|
|
2015
Q4 | $741K | Buy |
49,941
+885
| +2% | +$13.1K | ﹤0.01% | 1884 |
|
|
2015
Q3 | $805K | Hold |
49,056
| – | – | ﹤0.01% | 1842 |
|
|
2015
Q2 | $1.12M | Sell |
49,056
-1,598
| -3% | -$36.5K | ﹤0.01% | 1788 |
|
|
2015
Q1 | $770K | Buy |
50,654
+3,733
| +8% | +$56.7K | ﹤0.01% | 2022 |
|
|
2014
Q4 | $565K | Buy |
46,921
+4,910
| +12% | +$59.1K | ﹤0.01% | 2111 |
|
|
2014
Q3 | $476K | Sell |
42,011
-181
| -0.4% | -$2.05K | ﹤0.01% | 2251 |
|
|
2014
Q2 | $510K | Buy |
42,192
+559
| +1% | +$6.76K | ﹤0.01% | 2251 |
|
|
2014
Q1 | $485K | Buy |
41,633
+152
| +0.4% | +$1.77K | ﹤0.01% | 2076 |
|
|
2013
Q4 | $733K | Sell |
41,481
-1,117
| -3% | -$19.7K | ﹤0.01% | 2046 |
|
|
2013
Q3 | $613K | Buy |
42,598
+6,966
| +20% | +$100K | ﹤0.01% | 2117 |
|
|
2013
Q2 | $537K | Buy |
+35,632
| New | +$537K | ﹤0.01% | 1986 |
|